Anosmia

ANOSMIA

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G52.0, R43.0 Hospital discharge: ICD-9 — 3520 Hospital discharge: ICD-8 — 35600 Cause of death: ICD-10 — G52.0, R43.0 Cause of death: ICD-9 — 3520 Cause of death: ICD-8 — 35600 2 out of 7 registries used, show all original rules.	997
4. Check minimum number of events None	997
5. Include endpoints None	997
6. Filter based on genotype QC (FinnGen only)	997

Control definitions (FinnGen only)

Control exclude: NEURO_COMORBIDITIES

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	ANOSMIA
CONTROL_EXCLUDE	NEURO_COMORBIDITIES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G520\|R430
HD_ICD_9	3520
HD_ICD_8	35600
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G520\|R430
COD_ICD_9	3520
COD_ICD_8	35600
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Anosmia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Disorders of olfactory nerve

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	5836	3712	2100
Only index persons	5668	3636	2032
Unadjusted period prevalence (%)
Whole population	0.09	0.11	0.06
Only index persons	0.11	0.13	0.08
Median age at first event (years)
Whole population	56.21	56.84	55.27
Only index persons	56.18	56.77	55.13

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	997	678	319
Unadjusted period prevalence (%)	0.20	0.23	0.14
Median age at first event (years)	56.87	56.36	57.94

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
910: Matched controls
9029

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R43.0

ICD-10 Finland

Anosmia

4503599627370496.0

323.0

877

205

Kela drug reimbursment

Chronic hypertension

+∞

163.0

152

103

Kela drug reimbursment

Diabetes, insulin-treated

1578.4

143.2

136

H03AA01

ATC

levothyroxine sodium; systemic

44.1

142.4

177

215

Kela drug reimbursment

Diabetes, non-insulin-treated

+∞

140.9

132

I48

ICD-10 Finland

Atrial fibrillation and flutter

94.6

119.4

131

A10BA02

ATC

metformin; oral

40.8

117.9

149

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

38.2

112.4

144

I25.1

ICD-10 Finland

Atherosclerotic heart disease

100.1

105.4

115

C07AB07

ATC

bisoprolol; oral

6.0

98.2

323

756

N06AB04

ATC

citalopram; systemic

14.0

89.5

160

135

N06AX16

ATC

venlafaxine; oral

42.9

89.0

111

N06AB10

ATC

escitalopram; oral

13.7

87.5

158

136

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

29.6

81.5

111

207

Kela drug reimbursment

Chronic arrhythmias

154.3

81.2

B01AA03

ATC

warfarin; systemic

34.4

80.1

105

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

152.3

80.1

N06AX11

ATC

mirtazapine; oral

5.8

78.3

253

558

T90

ICPC

Diabetes non-insulin dependent

15.6

77.9

132

I10

ICD-10 Finland

Essential (primary) hypertension

3.9

73.8

430

1699

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

12.6

71.8

134

122

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

4.8

71.2

281

766

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

62.7

69.7

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

69.4

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.1

69.1

340

1143

C03CA01

ATC

furosemide; systemic

9.1

68.4

153

196

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

57.7

67.9

F32.9

ICD-10 Finland

Depressive episode, unspecified

28.9

65.9

R43.8

ICD-10 Finland

Other and unspecified disturbances of smell and taste

62.9

65.4

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

13.3

65.1

118

100

R01AD09

ATC

mometasone; nasal

3.2

61.1

508

2524

C01DA14

ATC

isosorbide mononitrate; oral

32.3

58.9

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

7.8

56.9

139

203

R07.4

ICD-10 Finland

Chest pain, unspecified

4.3

55.9

242

701

B01AC04

ATC

clopidogrel; oral

17.1

54.5

N06AB03

ATC

fluoxetine; oral

12.2

53.5

100

N02AX02

ATC

tramadol; systemic, rectal

3.3

53.3

366

1539

C08CA01

ATC

amlodipine; oral

3.9

52.4

252

798

R01AD08

ATC

fluticasone; nasal

3.3

51.5

345

1418

AN1

Coronary angiography

34.5

50.0

I50.9

ICD-10 Finland

Heart failure, unspecified

61.1

49.8

UDH02

NOMESCO Finland

Rhinopharyngoscopy

7.9

49.5

119

168

N06AX21

ATC

duloxetine; oral

15.8

49.3

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

94.6

49.2

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

174.2

48.1

N02BE01

ATC

paracetamol; systemic, rectal

3.4

47.7

761

5428

H02AB02

ATC

dexamethasone; systemic

28.3

46.8

C07AB02

ATC

metoprolol; systemic

5.9

45.8

138

266

E11

ICD-10 Finland

Type 2 diabetes mellitus

14.2

45.5

AA1AD

NOMESCO Finland

CT of head and brain

4.1

44.6

194

552

XF404

NOMESCO Finland

Ambulatory ECG

16.8

43.9

UJF32

NOMESCO Finland

Coloscopy

3.7

43.9

222

720

A02BC02

ATC

pantoprazole; systemic

2.7

43.9

536

3140

A03FA01

ATC

metoclopramide; systemic, rectal

5.3

43.8

144

307

PHD99

NOMESCO Finland

Resection of other vein

443.4

43.4

R06.0

ICD-10 Finland

Dyspnoea

4.1

43.2

189

540

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

119.7

43.0

N05BA04

ATC

oxazepam; oral

4.4

42.7

172

454

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

81.7

42.1

115

Kela drug reimbursment

Breast cancer

+∞

41.8

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

10.2

41.7

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

19.6

41.3

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

7.3

41.2

104

157

N03AX16

ATC

pregabalin; oral

3.6

41.0

210

684

H02AB06

ATC

prednisolone; systemic

2.7

40.8

413

2138

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

12.3

40.7

N06AB06

ATC

sertraline; oral

14.7

40.5

N05AH04

ATC

quetiapine; oral

7.7

40.0

138

104

Kela drug reimbursment

Thyroid insufficiency

145.0

39.9

A10AE04

ATC

insulin glargine; parenteral

+∞

39.7

R01AD12

ATC

fluticasone furoate; nasal

2.9

39.6

319

1430

A10BH01

ATC

sitagliptin; oral

399.9

39.2

G52.0

ICD-10 Finland

Disorders of olfactory nerve

+∞

38.7

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

389.1

38.2

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

389.1

38.2

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.9

38.1

302

1334

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

87.1

37.9

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

10.2

37.9

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

+∞

37.6

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

6.2

37.1

105

185

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

103.4

36.9

Z01.8

ICD-10 Finland

Other specified special examinations

3.4

36.9

203

693

SPAT1262

SPAT

Handing over of treatment supplies

7.3

36.7

137

TFP20

NOMESCO Finland

Cardiodefibrillation

+∞

36.6

R53

ICD-10 Finland

Malaise and fatigue

4.1

36.3

154

423

A02BC05

ATC

esomeprazole; systemic

2.6

35.6

364

1855

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

6.2

35.2

100

177

C10AA05

ATC

atorvastatin; oral

2.8

35.1

270

1161

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.5

34.8

372

1934

XF402

NOMESCO Finland

ECG with work load test

7.1

34.3

132

P76

ICPC

Depressive disorder

25.0

34.1

N05CF01

ATC

zopiclone; oral

3.1

33.6

220

845

130

Kela drug reimbursment

Malignant tumour

+∞

33.4

45499

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

+∞

33.4

C10AA01

ATC

simvastatin; oral

2.6

33.2

305

1451

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

10.7

33.1

K78

ICPC

Atrial fibrillation/flutter

45.9

32.9

B01AF02

ATC

apixaban; oral

28.5

32.5

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.6

32.1

286

1328

C09AA05

ATC

ramipril; oral

4.0

32.0

141

398

N06AB05

ATC

paroxetine; oral

27.8

31.6

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

6.1

31.5

160

N06AX12

ATC

bupropion; oral

54.4

31.4

A10BK03

ATC

empagliflozin; oral

+∞

31.3

4549X

ICD-9 Finland

Varicose veins of lower extremities, Without mention of ulcer or inflammation

+∞

31.3

JN4BD

NOMESCO Finland

Extensive body CT

8.7

31.3

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.3

31.3

455

2724

G47.3

ICD-10 Finland

Sleep apnoea

3.4

31.1

165

543

J01DB01

ATC

cefalexin; oral

2.5

30.7

699

5175

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

30.3

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

7.1

30.1

114

R42

ICD-10 Finland

Dizziness and giddiness

3.1

30.1

188

695

PHD76

NOMESCO Finland

Resection of long saphenous vein

309.0

29.9

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.3

29.5

386

2177

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

+∞

29.2

XF400

NOMESCO Finland

ECG with 12 standard connections

4.7

28.8

103

237

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.6

28.3

248

1130

R03AC02

ATC

salbutamol; inhalant

2.2

28.2

433

2617

R4110

NOMESCO Finland

Physiotherapy

2.8

27.9

207

853

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

9.4

27.6

WX408

NOMESCO Finland

General anesthesy, balanced

2.9

27.4

197

793

I49.3

ICD-10 Finland

Ventricular premature depolarization

11.6

27.2

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

+∞

27.1

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

5.0

26.9

193

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

275.9

26.7

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

275.9

26.7

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

275.9

26.7

PJA12

NOMESCO Finland

Sentinel node biopsy

18.4

26.6

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.5

26.2

154

B01AB05

ATC

enoxaparin; parenteral

2.7

26.2

202

848

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

3.1

26.1

164

605

N05BA12

ATC

alprazolam; oral

6.6

26.0

111

R50.9

ICD-10 Finland

Fever, unspecified

4.3

26.0

103

262

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

74.1

25.8

A02BC03

ATC

lansoprazole; oral

2.5

25.8

244

1152

N05CD07

ATC

temazepam; oral

5.2

25.7

171

DM1CG

NOMESCO Finland

Paranasal sinuses and face area extensive MRI examination with high intensity magnet

137.5

25.6

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

25.7

25.3

N06AX26

ATC

vortioxetine; oral

30.7

25.0

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

9.7

24.8

A04AA02

ATC

granisetron; systemic, transdermal

254.1

24.7

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

254.1

24.7

A06AC01

ATC

ispaghula (psylla seeds); oral

2.6

24.4

199

861

A06AD11

ATC

lactulose; oral

4.6

24.4

209

E03

ICD-10 Finland

Other hypothyroidism

35.2

24.3

C03AA03

ATC

hydrochlorothiazide; oral

6.7

24.2

M03BX02

ATC

tizanidine; oral

2.1

24.2

551

3839

C07AA05

ATC

propranolol; systemic

3.1

24.1

146

523

J01AA02

ATC

doxycycline; systemic

2.2

24.0

687

5260

5611

FHL

Vena saphena Magna and / or swarm of nodule and possible local emissions

+∞

24.0

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

5.1

24.0

162

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

38.3

23.9

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

68.6

23.8

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.5

23.7

210

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

88.2

23.7

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

243.6

23.7

N16

ICPC

Disturbance of smell/taste

127.0

23.6

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

127.0

23.6

M54.5

ICD-10 Finland

Low back pain

2.3

23.3

267

1378

N06AX03

ATC

mianserin; oral

18.9

23.0

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

+∞

22.9

N06AA09

ATC

amitriptyline; systemic

5.4

22.8

136

S18

ICPC

Laceration/cut

2.1

22.7

329

1883

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

40.8

22.7

A10BB12

ATC

glimepiride; oral

233.2

22.6

D64.9

ICD-10 Finland

Anaemia, unspecified

14.5

22.6

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

121.8

22.6

N03AX12

ATC

gabapentin; oral

3.3

22.5

124

414

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

8.6

22.4

I20.99

ICD-10 Finland

Angina pectoris, unspecified

45.8

22.3

C09CA06

ATC

candesartan; oral

2.8

22.2

164

666

Angiography of the heart and coronary arteries

24.4

22.1

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

13.0

22.1

WX110

NOMESCO Finland

Local anesthesy

2.0

22.1

563

4032

I47.1

ICD-10 Finland

Supraventricular tachycardia

52.9

22.1

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

21.9

R51.80

ICD-10 Finland

Headache

3.4

21.8

115

372

G44.2

ICD-10 Finland

Tension-type headache

3.3

21.7

117

385

C01AA05

ATC

digoxin; systemic

81.3

21.7

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

9.7

21.1

F32

ICD-10 Finland

Depressive episode

15.8

21.0

C03DA01

ATC

spironolactone; oral

8.3

21.0

J31.0

ICD-10 Finland

Chronic rhinitis

3.8

21.0

256

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

+∞

20.8

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

+∞

20.8

A04AA55

ATC

palonosetron, combinations; systemic

+∞

20.8

TFP34

NOMESCO Finland

Electrophysiological investigation

+∞

20.8

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.7

20.8

152

612

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.9

20.8

135

505

F34.1

ICD-10 Finland

Dysthymia

77.8

20.7

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.9

20.7

244

L28

ICPC

Limited function/disability (L)

3.4

20.7

108

347

I49.5

ICD-10 Finland

Sick sinus syndrome

212.4

20.6

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.5

20.5

181

811

P03

ICPC

Feeling depressed

6.8

20.5

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

42.3

20.4

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

4.3

20.4

192

TPH04

NOMESCO Finland

Cathetrisation of vein

2.9

20.1

130

482

R02

ICPC

Shortness of breath/dyspnoea

3.8

20.1

245

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

+∞

19.8

A10AE05

ATC

insulin detemir; parenteral

+∞

19.8

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

+∞

19.8

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

+∞

19.8

L02BA01

ATC

tamoxifen; oral

202.1

19.5

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

202.1

19.5

N06AG02

ATC

moclobemide; oral

18.0

19.5

M01AE03

ATC

ketoprofen; systemic, rectal

2.0

19.5

308

1805

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

12.9

19.4

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.6

19.3

275

C01BC04

ATC

flecainide; systemic

46.6

19.2

C08DB01

ATC

diltiazem; oral

22.9

19.0

A04

ICPC

Weakness/tiredness general

3.7

18.9

252

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

15.1

18.9

R60.0

ICD-10 Finland

Localized oedema

4.0

18.8

207

UKC02

NOMESCO Finland

Cystoscopy

3.1

18.8

111

389

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

18.7

M79.6

ICD-10 Finland

Pain in limb

2.1

18.6

276

1567

N02AJ06

ATC

codeine and paracetamol; systemic

2.1

18.6

274

1553

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

2.3

18.5

198

974

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

3.7

18.5

246

M04AA01

ATC

allopurinol; systemic

4.9

18.5

129

N02AA05

ATC

oxycodone; systemic

4.3

18.2

168

C08CA13

ATC

lercanidipine; oral

4.3

18.2

173

A04AA01

ATC

ondansetron; systemic, rectal

7.7

18.2

C61

ICD-10 Finland

Malignant neoplasm of prostate

12.6

18.1

ZXA00

NOMESCO Finland

Right side

2.2

17.9

220

1152

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

15.6

17.9

J01MA02

ATC

ciprofloxacin; systemic

2.0

17.9

289

1696

R13

ICD-10 Finland

Dysphagia

4.9

17.9

129

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.5

17.7

149

116

Kela drug reimbursment

Prostate cancer

+∞

17.7

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

+∞

17.7

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

+∞

17.7

UDM02

NOMESCO Finland

Sinoscopy

7.7

17.7

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.8

17.7

457

3179

C10AX09

ATC

ezetimibe; oral

4.5

17.6

145

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

10.0

17.6

F51.0

ICD-10 Finland

Nonorganic insomnia

3.4

17.6

279

I20.09

ICD-10 Finland

Unstable angina

95.9

17.5

SPAT1263

SPAT

Sampling

2.0

17.5

304

1831

E03.89

ICD-10 Finland

Other specified hypothyroidism

181.5

17.5

K30

ICD-10 Finland

Functional dyspepsia

3.2

17.5

314

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

3.4

17.4

270

I35.0

ICD-10 Finland

Aortic (valve) stenosis

29.1

17.4

K80

ICPC

Cardiac arrhythmia NOS

4.8

17.3

125

N06AA12

ATC

doxepin; systemic

11.3

17.2

L03

ICPC

Low back symptom/complaint

2.2

17.2

193

966

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

3.4

17.1

263

N05AH03

ATC

olanzapine; systemic

31.8

17.0

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

31.8

17.0

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

4.6

16.9

137

ZX120

NOMESCO Finland

Intravenous

4.9

16.9

119

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.6

16.9

227

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

7.2

16.9

HAC20

NOMESCO Finland

Total mastectomy

25.9

16.9

J01CA04

ATC

amoxicillin; systemic

1.9

16.9

680

5459

A02BA02

ATC

ranitidine; systemic

2.5

16.9

143

621

E66.01

ICD-10 Finland

Obesity due to excess calories

6.3

16.8

F41.1

ICD-10 Finland

Generalized anxiety disorder

19.5

16.8

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.8

16.7

467

3309

C08CA02

ATC

felodipine; oral

6.2

16.7

I50.1

ICD-10 Finland

Left ventricular failure

+∞

16.6

L01BC06

ATC

capecitabine; oral

+∞

16.6

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

+∞

16.6

L03AA02

ATC

filgrastim; parenteral

+∞

16.6

A10BD07

ATC

metformin and sitagliptin; systemic

+∞

16.6

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

+∞

16.6

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.7

16.6

123

497

HAB40

NOMESCO Finland

Wedge excision of mammary gland

16.5

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

6.0

16.4

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.2

16.3

195

1002

N05CF02

ATC

zolpidem; oral

2.6

16.3

123

502

C09AA02

ATC

enalapril; systemic

3.0

16.0

351

C07AG02

ATC

carvedilol; oral

9.6

15.9

T36

ICD-10 Finland

Poisoning by systemic antibiotics

14.7

15.8

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.6

15.7

119

485

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

15.6

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

15.6

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

+∞

15.6

M01AE02

ATC

naproxen; oral, rectal

1.8

15.6

467

3352

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

26.5

15.6

R43

ICD-10 Finland

Disturbances of smell and taste

85.7

15.5

I50.0

ICD-10 Finland

Congestive heart failure

85.7

15.5

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

15.5

352

2310

K59.0

ICD-10 Finland

Constipation

5.2

15.5

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

161.0

15.5

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

4.0

15.5

165

K02.1

ICD-10 Finland

Caries of dentine

1.8

15.4

459

3283

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.9

15.4

314

1987

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.9

15.4

100

371

M25.5

ICD-10 Finland

Pain in joint

2.0

15.3

231

1307

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

7.6

15.2

N05BE01

ATC

buspirone; oral

28.9

15.2

WX002

NOMESCO Finland

Sedation and analgesia

2.3

15.1

152

720

P01AB01

ATC

metronidazole; oral, rectal

1.8

15.1

324

2080

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.8

15.0

102

389

N03AG01

ATC

valproic acid; systemic, rectal

7.5

15.0

Z01.7

ICD-10 Finland

Laboratory examination

2.7

14.9

105

409

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.1

14.9

204

1108

Z01.2

ICD-10 Finland

Dental examination

1.8

14.8

351

2326

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.6

14.8

198

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.8

14.7

363

C08DA01

ATC

verapamil; systemic

8.4

14.7

WX892

NOMESCO Finland

Monitored bed care

7.6

14.7

WF002

NOMESCO Finland

Radical radiotherapy

18.5

14.6

N05BA01

ATC

diazepam; systemic, rectal

3.4

14.6

221

XX3DW

NOMESCO Finland

Time consuming IT work

4.9

14.6

102

A10BH05

ATC

linagliptin; oral

+∞

14.6

L03AA13

ATC

pegfilgrastim; parenteral

+∞

14.6

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

+∞

14.6

R43.1

ICD-10 Finland

Parosmia

80.6

14.5

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

80.6

14.5

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.5

14.5

116

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

14.4

586

4572

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

3.1

14.4

279

ZX090

NOMESCO Finland

Other technic of radiotherapy

150.7

14.4

N06AX22

ATC

agomelatine; oral

150.7

14.4

A02BC01

ATC

omeprazole; systemic

2.1

14.4

183

963

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

36.3

14.4

J01FA06

ATC

roxithromycin; oral

1.8

14.4

316

2039

E0000UV

ATC

1.8

14.4

299

1895

C10AA07

ATC

rosuvastatin; oral

2.2

14.3

162

808

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.0

14.3

227

1305

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

14.3

122

530

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.3

14.2

144

682

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

27.4

14.2

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

27.4

14.2

ZXA05

NOMESCO Finland

Left side

2.0

14.2

198

1082

N03AE01

ATC

clonazepam; systemic

5.5

14.2

C09BA02

ATC

enalapril and diuretics; systemic

5.6

14.2

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

8.7

14.2

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.1

14.2

173

894

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

14.2

216

1220

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

4.8

14.1

101

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.4

14.0

128

575

R03DC03

ATC

montelukast; oral

2.4

14.0

129

586

P01

ICPC

Feeling anxious/nervous/tense

4.2

13.9

131

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.4

13.9

120

526

G04BD12

ATC

mirabegron; oral

2.8

13.8

347

T90.5

ICD-10 Finland

Sequelae of intracranial injury

17.7

13.8

A12BA01

ATC

potassium chloride; oral

53.6

13.8

N06AB08

ATC

fluvoxamine; oral

20.2

13.7

SPAT1249

SPAT

Treatment-related counselling outside office

1.8

13.7

288

1823

E66.8

ICD-10 Finland

Other obesity

8.7

13.7

UDQ12

NOMESCO Finland

Flexible laryngoscopy

4.1

13.7

133

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

4.6

13.6

105

M01AH05

ATC

etoricoxib; oral

1.7

13.6

511

3860

M01AX17

ATC

nimesulide; oral

2.0

13.6

204

1146

I20.90

ICD-10 Finland

Angina pectoris, unspecified

75.5

13.5

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

+∞

13.5

45599

ICD-8 Finland

Haemorrhoids

+∞

13.5

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

+∞

13.5

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

+∞

13.5

A10BK01

ATC

dapagliflozin; oral

+∞

13.5

J01DA01

ATC

[U] cefalexin; systemic

1.7

13.5

484

3603

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.4

13.5

120

534

A11

ICPC

Chest pain NOS

3.8

13.5

155

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

5.1

13.4

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.3

13.3

215

SPAT1097

SPAT

Recording of ECG

2.6

13.3

102

417

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

6.0

13.3

DM1BD

NOMESCO Finland

Extensive CT of paranasal sinuses and face area

21.3

13.3

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.8

13.2

330

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

5.4

13.1

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

40.3

13.1

I25

ICD-10 Finland

Chronic ischaemic heart disease

40.3

13.1

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

12.3

13.1

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

12.3

13.1

UJF30

NOMESCO Finland

Ileoscopy through colon

3.2

13.0

225

JN3AD

NOMESCO Finland

Abdominal CT examination

4.1

13.0

130

XF640

NOMESCO Finland

19.2

12.9

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

19.2

12.9

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

19.2

12.9

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

22.7

12.9

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

50.2

12.8

A28

ICPC

Limited function/disability NOS

3.1

12.7

244

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.4

12.7

115

515

Z51.5

ICD-10 Finland

Palliative care

9.7

12.7

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

12.7

200

1140

D07AB02

ATC

hydrocortisone butyrate; topical

1.9

12.7

215

1261

L17

ICPC

Foot/toe symptom/complaint

2.0

12.7

186

1031

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.7

12.7

471

3521

R05

ICPC

Cough

2.0

12.6

177

962

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

12.6

532

4115

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

70.1

12.6

R06AE07

ATC

cetirizine; oral

1.7

12.5

340

2318

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

7.1

12.5

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

32.2

12.5

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

12.5

190

1067

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

+∞

12.5

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

+∞

12.5

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

+∞

12.5

SPAT1153

SPAT

Removal of sutures

1.8

12.5

240

1469

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

20.2

12.4

D11

ICPC

Diarrhoea

2.8

12.4

303

M48.0

ICD-10 Finland

Spinal stenosis

2.7

12.4

346

R01AD11

ATC

triamcinolone; nasal

2.7

12.4

328

Z71.8

ICD-10 Finland

Other specified counselling

2.0

12.4

166

889

WZA90

NOMESCO Finland

Other doctors statement

2.0

12.3

182

1012

P06

ICPC

Sleep disturbance

3.2

12.3

206

F32.1

ICD-10 Finland

Moderate depressive episode

10.6

12.2

HA1AA

NOMESCO Finland

X-ray mammography

4.7

12.2

N06AX05

ATC

trazodone; oral

37.7

12.2

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

37.7

12.2

XA800

NOMESCO Finland

Neuropsychological investigation

7.5

12.2

SPAT1104

SPAT

Monitoring of emergency patient

3.9

12.2

128

R04.0

ICD-10 Finland

Epistaxis

3.9

12.2

128

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

12.1

387

2761

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.3

12.1

186

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

12.1

302

2003

WX872

NOMESCO Finland

Intensive care

16.0

12.1

B03BA03

ATC

hydroxocobalamin; parenteral

6.6

12.0

WZC30

NOMESCO Finland

Teaching

3.0

12.0

244

TPH07

NOMESCO Finland

Cathetrisation of artery

4.7

11.9

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.7

11.9

311

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

46.8

11.8

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

5.9

11.8

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

3.1

11.7

208

R55

ICD-10 Finland

Syncope and collapse

3.1

11.7

214

J01FF01

ATC

clindamycin; systemic

1.9

11.6

189

1087

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.6

11.6

353

P20

ICPC

Memory disturbance

2.6

11.6

364

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

30.1

11.6

J01FA10

ATC

azithromycin; systemic

1.6

11.6

468

3544

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

65.1

11.6

C50

ICD-10 Finland

Malignant neoplasm of breast

65.1

11.6

C02EA02

ATC

65.1

11.6

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

65.1

11.6

J20

ICD-10 Finland

Acute bronchitis

2.7

11.6

303

C02AC05

ATC

moxonidine; oral

19.0

11.5

C08CA10

ATC

nilvadipine; oral

23.0

11.5

L02BG04

ATC

letrozole; oral

11.2

11.5

G04CA02

ATC

tamsulosin; oral

2.2

11.5

126

618

ZXA10

NOMESCO Finland

Bilateral

2.1

11.5

139

713

R11

ICD-10 Finland

Nausea and vomiting

4.1

11.5

110

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.0

11.5

115

I20.00

ICD-10 Finland

Unstable angina

+∞

11.4

A10BH02

ATC

vildagliptin; oral

+∞

11.4

I42.0

ICD-10 Finland

Dilated cardiomyopathy

+∞

11.4

A10BJ06

ATC

semaglutide; parenteral

+∞

11.4

AN3

Balloon angioplasty and metallic stent

+∞

11.4

A10AA02

ATC

+∞

11.4

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

+∞

11.4

I25.2

ICD-10 Finland

Old myocardial infarction

+∞

11.4

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

11.4

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

120.2

11.4

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.7

11.4

307

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.7

11.4

136

R07.3

ICD-10 Finland

Other chest pain

3.1

11.4

216

S06.0

ICD-10 Finland

Concussion

2.8

11.4

276

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

11.3

378

2714

R5140

NOMESCO Finland

Monitoring the use of the aid

2.8

11.3

270

N39.4

ICD-10 Finland

Other specified urinary incontinence

3.0

11.3

218

C09DA03

ATC

valsartan and diuretics; oral

6.6

11.2

S06.3

ICD-10 Finland

Focal brain injury

10.6

11.2

R07.0

ICD-10 Finland

Pain in throat

3.3

11.2

175

M01AB05

ATC

diclofenac; systemic, rectal

1.6

11.2

559

4454

M03BC01

ATC

orphenadrine (citrate); systemic

1.9

11.2

170

952

R05

ICD-10 Finland

Cough

2.0

11.2

159

868

SPAT1216

SPAT

Assessment of functional ability

2.4

11.2

100

444

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.2

11.1

115

549

M01AX05

ATC

glucosamine; oral

1.9

11.1

168

939

J01MA12

ATC

levofloxacin; systemic

2.3

11.1

105

479

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

4.2

11.1

XKD00

NOMESCO Finland

Uroflowmetry

2.5

11.1

382

M03BC51

ATC

orphenadrine, combinations; systemic

1.8

11.0

219

1347

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

10.1

11.0

AA1BD

NOMESCO Finland

Extensive CT of head and brain

10.1

11.0

J34.2

ICD-10 Finland

Deviated nasal septum

3.5

10.9

146

KMAK

NOMESCO Finland

1.6

10.9

413

3057

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

43.4

10.9

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

43.4

10.9

C09CA01

ATC

losartan; oral

2.0

10.8

142

752

J33.8

ICD-10 Finland

Other polyp of sinus

5.0

10.8

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.6

10.7

330

SPAT1301

SPAT

No procedures

1.8

10.7

213

1307

JN4AD

NOMESCO Finland

Body CT examination

5.9

10.7

I34.1

ICD-10 Finland

Mitral (valve) prolapse

28.1

10.7

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.6

10.7

322

J01EA01

ATC

trimethoprim; systemic

1.9

10.7

176

1012

N05AB03

ATC

perphenazine; systemic, rectal

21.5

10.6

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

10.6

136

711

M02AA07

ATC

piroxicam; topical

1.7

10.6

294

1996

WX402

NOMESCO Finland

General anaesthesia

2.3

10.6

102

471

F99

ICD-10 Finland

Mental disorder, not otherwise specified

60.1

10.6

R52.2

ICD-10 Finland

Other chronic pain

6.4

10.6

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.6

10.6

326

M01AC06

ATC

meloxicam; systemic, rectal

1.7

10.5

297

2026

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.6

10.5

334

2355

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

3.1

10.4

185

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.7

10.4

313

2170

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

110.1

10.4

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

110.1

10.4

A10AA01

ATC

+∞

10.4

I48.2

ICD-10 Finland

Chronic atrial fibrillation

+∞

10.4

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

10.4

AN4

Balloon angioplasty and drug eluding stent

+∞

10.4

A10BG03

ATC

pioglitazone; oral

+∞

10.4

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

5.7

10.4

D01

ICPC

Abdominal pain/cramps general

2.6

10.4

297

A46

ICD-10 Finland

Erysipelas

2.6

10.3

287

SPAT1254

SPAT

Administration of medicine

2.7

10.3

263

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

32.6

10.3

S29

ICPC

Skin symptom/complaint other

2.1

10.3

124

634

L08

ICPC

Shoulder symptom/complaint

1.9

10.2

156

874

S06.2

ICD-10 Finland

Diffuse brain injury

18.8

10.2

R05FB02

ATC

cough suppressants and expectorants

1.7

10.2

289

1969

H53.1

ICD-10 Finland

Subjective visual disturbances

3.3

10.2

160

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

23.4

10.2

JHB00

NOMESCO Finland

Hemorrhoidectomy

23.4

10.2

L57.0

ICD-10 Finland

Actinic keratosis

2.6

10.2

302

SPAT1312

SPAT

General health counselling

1.7

10.2

238

1535

J02AC01

ATC

fluconazole; systemic

1.6

10.2

318

2224

R60.9

ICD-10 Finland

Oedema, unspecified

4.6

10.2

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

10.1

393

H02AB04

ATC

methylprednisolone; systemic

2.2

10.1

108

523

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

6.3

10.1

R00.1

ICD-10 Finland

Bradycardia, unspecified

14.6

10.0

SPAT1240

SPAT

Therapeutic discussion

3.4

9.9

147

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

40.1

9.9

XCK10

NOMESCO Finland

Photography of fundus of eye

2.9

9.9

210

N05BA06

ATC

lorazepam; systemic, sublingual

7.7

9.9

N03AF01

ATC

carbamazepine; oral, rectal

4.6

9.8

L01

ICPC

Neck symptom/complaint

2.2

9.8

108

528

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

26.1

9.8

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

9.8

118

601

K29.4

ICD-10 Finland

Chronic atrophic gastritis

10.7

9.7

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.5

9.7

R03BA08

ATC

ciclesonide; inhalant

2.6

9.7

283

R06AX27

ATC

desloratadine; oral

1.7

9.7

212

1337

F61.0

ICD-10 Finland

Mixed personality disorders

55.0

9.6

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

55.0

9.6

L02BG03

ATC

anastrozole; oral

55.0

9.6

S02.11

ICD-10 Finland

Fracture of base of skull, open

55.0

9.6

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.5

9.6

130

T86

ICPC

Hypothyroidism/myxoedema

11.4

9.5

K59.09

ICD-10 Finland

Constipation, unspecified

4.3

9.4

SPAT1229

SPAT

Assessment of need for aid

3.4

9.4

137

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

9.4

116

599

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

100.0

9.4

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

100.0

9.4

I48.1

ICD-10 Finland

Persistent atrial fibrillation

100.0

9.4

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

100.0

9.4

R03BB04

ATC

tiotropium bromide; inhalant

3.0

9.4

180

5612

FHL

Local excisions and / or perforations of relapsing varicose veins

+∞

9.4

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

+∞

9.4

AS4

Physiological pacemaker insertion DDD (R)

+∞

9.4

WF049

NOMESCO Finland

Radiotherapy of metastasis

+∞

9.4

A10AE06

ATC

insulin degludec; parenteral

+∞

9.4

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

+∞

9.4

AN2

Balloon angioplasty, including several vessels

+∞

9.4

A10BJ02

ATC

liraglutide; parenteral

+∞

9.4

128

Kela drug reimbursment

Cancers of female genital organs

+∞

9.4

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

+∞

9.4

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.1

9.3

103

507

UJH02

NOMESCO Finland

Anoscopy

5.4

9.3

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

12.4

9.3

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.9

9.3

153

878

SPAT1260

SPAT

Consultation of another employee

2.1

9.3

109

552

B01AC07

ATC

dipyridamole; systemic

10.7

9.2

A02BA04

ATC

nizatidine; systemic

3.0

9.2

183

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.1

9.2

167

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

9.5

9.2

M79.1

ICD-10 Finland

Myalgia

2.3

9.2

418

XF600

NOMESCO Finland

Bloodpressure measurement

4.4

9.2

R4190

NOMESCO Finland

Nutritional therapy

7.3

9.2

I49.1

ICD-10 Finland

Atrial premature depolarization

7.3

9.2

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.9

9.2

137

761

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

7.8

9.1

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.4

9.1

346

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

2.2

9.1

436

N19

ICD-10 Finland

Unspecified kidney failure

11.5

9.0

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

4.1

9.0

WF003

NOMESCO Finland

Adjuvant radiotherapy

15.6

9.0

F33

ICD-10 Finland

Recurrent depressive disorder

36.7

9.0

C07AB08

ATC

celiprolol; oral

36.7

9.0

K76

ICPC

Ischaemic heart dis without angina

36.7

9.0

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

6.5

8.9

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

4.0

8.9

M70.6

ICD-10 Finland

Trochanteric bursitis

2.2

8.9

472

D07AC01

ATC

betamethasone; topical

1.6

8.9

251

1695

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

24.0

8.9

G04BD04

ATC

oxybutynin; oral, transdermal

3.4

8.9

122

R74

ICPC

Upper respiratory infection acute

1.7

8.8

200

1271

H04.10

ICD-10 Finland

Dry eye syndrome

2.3

8.8

358

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.4

8.8

123

K29

ICPC

Cardiovascular sympt/complt other

5.0

8.8

C09DA01

ATC

losartan and diuretics; oral

3.0

8.8

172

P74

ICPC

Anxiety disorder/anxiety state

8.6

8.8

S80.0

ICD-10 Finland

Contusion of knee

2.9

8.7

179

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.2

8.7

421

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.9

8.7

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.3

8.7

376

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.5

8.7

264

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

14.0

8.7

L02AE02

ATC

leuprorelin; implant, parenteral

14.0

8.7

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

49.9

8.6

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

49.9

8.6

C09CA03

ATC

valsartan; oral

3.0

8.6

158

A01AB09

ATC

miconazole; local oral

2.6

8.6

247

C09DA06

ATC

candesartan and diuretics; oral

3.8

8.6

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.2

8.5

K94

ICPC

Phlebitis/thrombophlebitis

16.3

8.5

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

5.0

8.5

R03AK07

ATC

formoterol and budesonide; inhalant

1.9

8.5

138

788

X76

ICPC

Malignant neoplasm breast female

27.5

8.4

K29.3

ICD-10 Finland

Chronic superficial gastritis

5.2

8.4

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

89.9

8.4

I44.1

ICD-10 Finland

Atrioventricular block, second degree

89.9

8.4

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

89.9

8.4

TFP35

NOMESCO Finland

Electroanatomical mapping

89.9

8.4

T89

ICPC

Diabetes insulin dependent

89.9

8.4

H02AB07

ATC

prednisone; oral

2.1

8.4

481

A99

ICPC

Disease/condition unspecnature/site

2.8

8.4

188

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

12.8

8.3

ZZR00

NOMESCO Finland

Flap of skin

12.8

8.3

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.2

8.3

383

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

+∞

8.3

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

+∞

8.3

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

+∞

8.3

25009

ICD-8 Finland

Diabetes mellitus, Unspecified

+∞

8.3

C01BD01

ATC

amiodarone; systemic

+∞

8.3

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

+∞

8.3

Single vessel balloon catheter extension

+∞

8.3

L02BG06

ATC

exemestane; oral

+∞

8.3

I44.2

ICD-10 Finland

Atrioventricular block, complete

+∞

8.3

Coronary artery bypass surgery

+∞

8.3

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

8.3

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

+∞

8.3

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

+∞

8.3

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

+∞

8.3

WF004

NOMESCO Finland

Palliative radiotherapy

+∞

8.3

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

+∞

8.3

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

+∞

8.3

R01AD05

ATC

budesonide; nasal

2.4

8.3

305

WX722

NOMESCO Finland

PEEP

4.3

8.3

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.5

8.3

387

2952

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.2

8.3

135

E87.6

ICD-10 Finland

Hypokalaemia

10.8

8.3

B01AB10

ATC

tinzaparin; parenteral

3.6

8.2

103

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.9

8.2

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

8.1

539

4425

K02.0

ICD-10 Finland

Caries limited to enamel

2.0

8.1

101

523

EP1AE

NOMESCO Finland

Neck ultrasound examination

4.0

8.1

R20.2

ICD-10 Finland

Paraesthesia of skin

2.8

8.1

177

C07AB03

ATC

atenolol; systemic

5.4

8.1

J05AB01

ATC

aciclovir; systemic

1.8

8.1

161

981

201

Kela drug reimbursment

Chronic cardiac insufficiency

33.3

8.0

B01AC06

ATC

acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)

33.3

8.0

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

33.3

8.0

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

33.3

8.0

L15

ICPC

Knee symptom/complaint

1.8

8.0

159

967

P15

ICPC

Chronic alcohol abuse

8.9

8.0

SPAT1310

SPAT

Counselling related to known health issue

1.6

8.0

211

1398

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

10.0

8.0

C50.99

ICD-10 Finland

Breast, unspecified

22.0

8.0

XQ800

NOMESCO Finland

Prick test

2.5

8.0

251

J01FA09

ATC

clarithromycin; systemic

1.6

8.0

238

1628

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.9

7.9

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

7.9

310

2264

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.3

7.9

337

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

3.2

7.9

123

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.0

7.9

486

N07BB01

ATC

disulfiram; oral

6.6

7.8

M01AH01

ATC

celecoxib; oral (coxibs)

1.8

7.8

130

749

K86

ICPC

Hypertension uncomplicated

2.3

7.8

319

B81

ICPC

Anaemia vit B12/folate deficiency

6.1

7.8

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.7

7.8

196

1281

N06AA06

ATC

trimipramine; systemic

10.8

7.8

I95.1

ICD-10 Finland

Orthostatic hypotension

9.4

7.7

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

7.7

118

657

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

4.8

7.7

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

44.9

7.7

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

15.0

7.7

SPAT1285

SPAT

Provision of consultation response

3.4

7.7

104

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

5.6

7.6

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.0

7.6

508

N04BC05

ATC

pramipexole; oral

2.7

7.6

184

A07AA02

ATC

nystatin; oral

3.1

7.6

127

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

7.6

242

1680

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.9

7.6

155

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

7.5

776

6985

M54.2

ICD-10 Finland

Cervicalgia

2.5

7.5

229

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

8.9

7.5

E66.00

ICD-10 Finland

Metabolic syndrome

5.8

7.5

UDC00

NOMESCO Finland

Ear microscopy

2.5

7.5

230

R03BA05

ATC

fluticasone; inhalant

1.8

7.5

125

721

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

4.7

7.5

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.8

7.5

163

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.4

7.5

269

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

4.1

7.4

-50

ICPC

Medication/prescr/renewal

4.1

7.4

XF602

NOMESCO Finland

Bloodpressure monitoring

79.9

7.4

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

79.9

7.4

I20.01

ICD-10 Finland

Unstable angina

79.9

7.4

A10BB01

ATC

glibenclamide; oral

79.9

7.4

C02DE10

ATC

79.9

7.4

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

79.9

7.4

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

79.9

7.4

F31.8

ICD-10 Finland

Other bipolar affective disorders

79.9

7.4

AP1

Catheterization of the left side of the heart

79.9

7.4

C09AA03

ATC

lisinopril; oral

5.0

7.4

R51.81

ICD-10 Finland

Facial pain NOS

6.5

7.4

N05AA02

ATC

levomepromazine; systemic

13.3

7.3

K28

ICPC

Limited function/disability (K)

13.3

7.3

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

13.3

7.3

XX1XW

NOMESCO Finland

Extensive written report from radiologist

7.7

7.3

M79.7

ICD-10 Finland

Fibromyalgia

6.0

7.3

A03FA02

ATC

cisapride; oral, rectal

2.7

7.3

192

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

3.9

7.3

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

2.3

7.3

278

I47.2

ICD-10 Finland

Ventricular tachycardia

+∞

7.3

A10BG02

ATC

rosiglitazone; oral

+∞

7.3

B01AC24

ATC

ticagrelor; oral

+∞

7.3

L02BB03

ATC

bicalutamide; oral

+∞

7.3

4019X

ICD-9 Finland

Essential hypertension, Unspecified

+∞

7.3

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

7.3

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

+∞

7.3

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

+∞

7.3

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

+∞

7.3

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

+∞

7.3

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

+∞

7.3

N05AF03

ATC

chlorprothixene; systemic

+∞

7.3

AA1

Conventional CABG

+∞

7.3

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

+∞

7.3

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

+∞

7.3

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

7.3

C02LM02

ATC

+∞

7.3

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

+∞

7.3

IGY02

NOMESCO Finland

Psychiatric monitoring contact

+∞

7.3

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

+∞

7.3

280

Kela drug reimbursment

Clopidogrel

+∞

7.3

107

Kela drug reimbursment

Pernicious anaemia

+∞

7.3

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

+∞

7.3

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

+∞

7.3

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.1

7.3

385

M10.9

ICD-10 Finland

Gout, unspecified

4.2

7.3

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.6

7.2

210

1420

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.2

7.2

115

B01AE07

ATC

dabigatran etexilate; oral

5.4

7.2

G04BD07

ATC

tolterodine; oral

3.2

7.2

110

E000001

ATC

1.8

7.2

137

823

N03AX09

ATC

lamotrigine; oral

7.3

7.1

M05BX04

ATC

denosumab; parenteral

3.5

7.1

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.9

7.1

143

N06AX18

ATC

reboxetine; oral

29.9

7.1

R52.9

ICD-10 Finland

Pain, unspecified

2.4

7.1

255

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

7.1

199

1334

WX290

NOMESCO Finland

Other blockade of nerve

1.5

7.1

301

2229

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.8

7.1

167

E66.9

ICD-10 Finland

Obesity, unspecified

7.9

7.1

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

12.0

7.0

C07AB05

ATC

betaxolol; oral

12.0

7.0

S97

ICPC

Chronic ulcer skin

4.6

7.0

N17

ICPC

Vertigo/dizziness

2.1

7.0

373

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.3

7.0

270

H02BX01

ATC

methylprednisolone, combinations; systemic

2.8

7.0

158

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.9

7.0

146

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.8

7.0

119

691

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.0

6.9

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.6

6.9

196

W10

ICD-10 Finland

Fall on and from stairs and steps

3.0

6.9

125

C10AA04

ATC

fluvastatin; oral

2.6

6.9

178

K02

ICPC

Pressure/tightness of heart

5.8

6.9

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.3

6.9

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

13.7

6.9

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

4.6

6.9

L29

ICPC

Musculoskeletal sympt/complt other

2.4

6.8

247

-1

NOMESCO Finland

1.5

6.8

234

1649

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

4.8

6.8

SPAT1139

SPAT

Nutrition survey

4.4

6.8

G01AA10

ATC

clindamycin; vaginal

1.7

6.8

131

791

SPAT1053

SPAT

Memory test

1.9

6.8

538

B80

ICPC

Iron deficiency anaemia

10.9

6.8

H02

ICPC

Hearing complaint

1.9

6.7

539

DFF00

NOMESCO Finland

Pure tone audiometry

2.0

6.7

407

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

39.9

6.7

WX730

NOMESCO Finland

Conventional respirator

39.9

6.7

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

39.9

6.7

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

39.9

6.7

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

3.7

6.7

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

16.7

6.7

N05AF01

ATC

flupentixol; systemic

16.7

6.7

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

16.7

6.7

L02

ICPC

Back symptom/complaint

2.3

6.7

263

Z50.1

ICD-10 Finland

Other physical therapy

2.9

6.7

138

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

4.3

6.7

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.7

6.7

J05AB11

ATC

valaciclovir; oral

1.9

6.7

548

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

22.5

6.6

K74

ICPC

Ischaemic heart dis with angina

22.5

6.6

M01AG02

ATC

tolfenamic acid; oral, rectal

1.8

6.6

116

677

F43.8

ICD-10 Finland

Other reactions to severe stress

6.4

6.6

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

5.2

6.6

C07AA07

ATC

sotalol; systemic

7.8

6.6

N03AX11

ATC

topiramate; oral

5.5

6.6

I83

ICD-10 Finland

Varicose veins of lower extremities

5.5

6.6

J01FA15

ATC

telithromycin; oral

2.0

6.6

391

RD210

NOMESCO Finland

12.2

6.5

UJF92

NOMESCO Finland

Capsular endoscopy

12.2

6.5

ZX112

NOMESCO Finland

Subcutaneous

12.2

6.5

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

12.2

6.5

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

4.0

6.5

B01AB04

ATC

dalteparin; parenteral

3.6

6.5

M54.6

ICD-10 Finland

Pain in thoracic spine

2.7

6.5

158

K99

ICPC

Cardiovascular disease other

10.0

6.5

C09DA07

ATC

telmisartan and diuretics; oral

4.3

6.5

SPAT1043

SPAT

Audiometry

2.0

6.5

442

XA402

NOMESCO Finland

ENMG

4.1

6.5

R03AC03

ATC

terbutaline; inhalant

1.9

6.5

503

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.7

6.5

126

761

A79

ICPC

Malignancy NOS

69.6

6.4

F40.1

ICD-10 Finland

Social phobias

69.6

6.4

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

69.6

6.4

C02DE04

ATC

69.6

6.4

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

69.6

6.4

B03XA02

ATC

darbepoetin alfa; parenteral

69.6

6.4

F39

ICD-10 Finland

Unspecified mood [affective] disorder

69.6

6.4

B01AF03

ATC

edoxaban; oral

69.6

6.4

M54

ICD-10 Finland

Dorsalgia

2.0

6.4

378

A02BC04

ATC

rabeprazole; oral

2.3

6.4

268

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

14.3

6.4

R01AD01

ATC

beclometasone; nasal

1.8

6.4

119

712

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.2

6.3

270

L16

ICPC

Ankle symptom/complaint

2.1

6.3

317

A07EA06

ATC

budesonide; oral, local oral

3.6

6.3

M54.3

ICD-10 Finland

Sciatica

2.5

6.3

180

SPAT1211

SPAT

Application of soft bandage

2.3

6.3

250

R51

ICD-10 Finland

Headache

3.2

6.3

R00.2

ICD-10 Finland

Palpitations

2.7

6.3

145

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

6.5

6.3

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.7

6.3

156

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

11.0

6.3

C09CA07

ATC

telmisartan; oral

2.7

6.2

149

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

18.0

6.2

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

+∞

6.2

GD1LA

NOMESCO Finland

+∞

6.2

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

6.2

40199

ICD-8 Finland

Essential benign hypertension

+∞

6.2

PHD77

NOMESCO Finland

Resection of short saphenous vein

+∞

6.2

A04AD12

ATC

aprepitant; systemic

+∞

6.2

A11CC03

ATC

alfacalcidol; systemic

+∞

6.2

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

+∞

6.2

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

6.2

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

+∞

6.2

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

6.2

160

Kela drug reimbursment

exenatide

+∞

6.2

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

+∞

6.2

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

6.2

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

+∞

6.2

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

6.2

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

+∞

6.2

C90.0

ICD-10 Finland

Multiple myeloma

+∞

6.2

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

+∞

6.2

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

+∞

6.2

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

6.2

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

6.2

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

+∞

6.2

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

6.2

K59.1

ICD-10 Finland

Functional diarrhoea

3.1

6.2

100

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.5

6.2

183

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

26.6

6.2

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

26.6

6.2

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

26.6

6.2

K79

ICPC

Paroxysmal tachycardia

26.6

6.2

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

6.2

102

584

K85

ICPC

Elevated blood pressure

1.9

6.2

518

TKC20

NOMESCO Finland

Catheterisation of bladder

3.3

6.1

N05AB04

ATC

prochlorperazine; systemic, rectal

5.0

6.1

M02AA10

ATC

ketoprofen; topical

1.7

6.1

120

725

A10BX01

ATC

guar gum; systemic

6.3

6.1

D82

ICPC

Teeth/gum disease

1.5

6.1

263

1941

A03

ICPC

Fever

1.8

6.1

557

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.2

6.1

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.0

6.1

415

P29

ICPC

Psychological sympt/compl other

4.2

6.1

N30.0

ICD-10 Finland

Acute cystitis

1.9

6.1

447

J45

ICD-10 Finland

Asthma

2.1

6.0

310

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

3.6

6.0

A06AC51

ATC

ispaghula, combinations; systemic

2.9

6.0

124

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.9

6.0

420

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

4.9

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

307

747

5.43

121.61

3.0

1.4

635.3

391.1

ng/l

3.00

255

567

(3032080) INR in Blood by Coagulation assay

397

1390

4.03

95.46

7.9

2.0

1.2

1.0

inr

2.39

387

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

517

2325

3.50

82.29

5.7

2.6

10.6

11.5

umol/l

1.21

487

2143

(3013650) Neutrophils [#/volume] in Blood by Automated count

596

2942

3.50

81.22

8.2

5.2

3.9

e9/l

0.08

525

2515

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

486

2127

3.46

80.37

5.7

2.7

1.2

mmol/l

4.21

451

1799

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

519

2392

3.39

78.36

6.2

3.0

1.2

mmol/l

3.89

471

2006

(3022217) INR in Platelet poor plasma by Coagulation assay

159

313

5.78

77.72

24.0

3.4

1.2

1.0

inr

1.19

(3013826) Glucose [Moles/volume] in Serum or Plasma

557

2703

3.36

76.73

4.7

2.1

6.5

6.1

mmol/l

4.65

527

2416

(3018677) aPTT in Platelet poor plasma by Coagulation assay

172

375

5.27

74.95

2.1

1.4

29.5

28.3

1.13

167

365

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

342

1251

3.59

74.23

2.3

1.7

165.2

202.4

u/l

0.27

322

1152

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

262

803

4.02

73.87

2.4

1.5

2.9

2.5

mg/l

1.56

226

642

(3024561) Albumin [Mass/volume] in Serum or Plasma

434

1851

3.34

73.43

4.6

2.4

35.9

37.0

g/l

3.74

408

1646

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

467

2082

3.29

73.35

2.2

1.5

97.6

102.9

pmol/l

1.25

246

934

(3012095) Magnesium [Moles/volume] in Serum or Plasma

171

386

5.08

71.42

2.9

1.7

0.8

mmol/l

0.67

154

338

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

383

1564

3.31

68.84

3.9

1.7

24.2

19.3

ng/l

0.38

261

837

(3019198) Lymphocytes [#/volume] in Blood

539

2761

3.03

64.07

5.8

4.6

1.9

e9/l

0.57

463

2430

(3013115) Eosinophils [#/volume] in Blood

539

2784

3.00

62.70

5.8

4.6

0.2

e9/l

0.08

460

2425

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

741

4583

3.35

62.04

7.6

3.7

75.4

74.0

u/l

0.46

696

4150

(3001604) Monocytes [#/volume] in Blood

522

2662

2.98

61.95

5.8

4.6

0.6

0.5

e9/l

0.41

445

2295

(3006315) Basophils [#/volume] in Blood

524

2679

2.97

61.88

5.8

4.6

0.0

e9/l

0.42

443

2301

(3023368) Bacteria identified in Blood by Culture

245

802

3.68

61.78

4.3

2.4

—

(3012516) Albumin [Mass/volume] in Urine

257

871

3.58

61.43

3.4

1.6

55.2

672.6

mg/l

1.67

147

403

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

153

6.83

58.87

2.5

1.5

4.8

4.0

ug/l

0.36

132

(3009508) Creatinine [Moles/volume] in Urine

264

945

3.40

57.54

3.3

1.6

7.3

8.2

mmol/l

2.38

213

795

(3020682) Albumin/Creatinine [Ratio] in Urine

260

923

3.41

57.41

4.1

1.8

10.3

6.0

mg/mmol

0.62

150

445

(3013707) Erythrocyte sedimentation rate by Westergren method

765

4974

3.26

55.56

4.4

3.3

11.2

9.8

mm/h

2.23

712

4521

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

121

250

5.31

55.49

4.0

2.7

235.3

228.5

u/l

0.32

116

236

(3033658) Prothrombin time (PT) actual/Normal

278

1055

3.23

54.74

4.2

2.1

91.0

96.9

3.54

272

1032

(3019309) Folate [Moles/volume] in Red Blood Cells

227

762

3.52

54.51

1.7

1.4

1051.8

1118.7

nmol/l

0.55

173

521

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

752

4869

3.17

54.46

4.5

2.2

14.8

14.4

pmol/l

5.39

680

4320

(42870588) Differential panel, method unspecified - Blood

363

1607

2.94

54.43

5.4

5.0

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

145

357

4.53

53.85

2.4

1.5

2.3

2.4

g/l

0.41

135

326

(3022948) Iron [Moles/volume] in Serum or Plasma

155

402

4.33

53.82

2.4

1.6

13.4

16.5

umol/l

4.87

146

362

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

197

608

3.74

53.68

4.5

1.6

89.5

359.4

ng/l

0.72

146

385

(3015377) Calcium [Moles/volume] in Serum or Plasma

361

1618

2.89

52.59

3.5

1.6

2.4

mmol/l

0.62

306

1311

(3006504) Eosinophils/100 leukocytes in Blood

480

2496

2.74

52.43

6.1

4.7

3.0

0.08

444

2295

(3019069) Monocytes/100 leukocytes in Blood

481

2509

2.73

52.14

6.3

4.9

8.5

0.14

446

2322

(3001122) Ferritin [Mass/volume] in Serum or Plasma

425

2087

2.77

51.83

3.3

1.8

119.2

111.9

ug/l

0.29

395

1927

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

134

320

4.63

51.64

2.5

1.6

22.5

28.4

4.13

119

270

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

169

487

3.93

50.69

1.7

1.4

—

(3002030) Lymphocytes/100 leukocytes in Blood

489

2601

2.69

50.55

6.3

4.7

29.0

30.2

1.47

452

2388

(3022096) Basophils/100 leukocytes in Blood

465

2418

2.69

50.23

6.2

4.8

0.7

0.18

430

2220

(3018010) Neutrophils/100 leukocytes in Blood

485

2577

2.68

50.13

6.0

4.6

56.5

55.5

0.96

448

2388

(3031040) Bacteria [#/volume] in Urine by Automated count

637

3908

2.70

48.51

5.5

2.9

2054.6

3102.7

e6/l

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

880

6451

4.05

47.91

5.6

2.7

1.9

2.3

mu/l

0.76

811

5700

(3003396) Base excess in Arterial blood by calculation

112

249

4.88

46.98

6.2

4.4

1.2

1.1

mmol/l

0.09

185

(3018418) pH of Serum or Plasma

307

1338

2.83

46.23

4.0

2.0

7.4

0.47

166

(3003458) Phosphate [Moles/volume] in Serum or Plasma

127

321

4.33

45.34

4.9

2.4

1.0

mmol/l

1.28

118

288

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

355

1699

2.66

44.16

4.0

2.2

—

(3000991) Gas panel - Venous blood

165

5.47

41.54

7.3

4.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

114

284

4.35

41.37

2.2

1.7

1.5

1.81

105

242

(40758558) Short blood count panel - Blood

275

1192

2.77

41.23

7.4

3.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

219

847

2.99

40.54

3.0

1.8

2.4

mmol/l

0.35

196

733

(3023520) Reticulocytes [#/volume] in Blood

194

5.00

39.98

2.5

1.6

68.5

65.5

e9/l

0.36

145

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

912

7093

4.31

39.91

15.9

5.7

21.9

22.6

mg/l

0.28

737

4765

(3044640) Blood type and Crossmatch panel - Blood

312

1464

2.61

39.73

2.3

1.5

—

(40768804) Tissue Pathology biopsy report

459

2586

2.40

39.15

2.4

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

329

1594

2.55

39.09

2.8

1.7

57.2

62.0

u/l

0.81

294

1442

(3037467) Urinalysis macro (dipstick) panel - Urine

653

4302

2.46

38.84

4.9

3.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

132

5.82

38.45

2.6

2.2

5.0

5.2

kpa

1.45

121

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

126

5.92

38.13

2.6

2.1

1.3

1.7

mmol/l

0.54

(3021960) Folate [Moles/volume] in Serum or Plasma

254

1098

2.73

37.93

1.6

1.3

19.8

21.8

nmol/l

1.29

221

861

(3009343) pH of Capillary blood

131

5.77

37.67

2.6

2.2

7.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

645

4265

2.41

37.43

3.2

2.1

50.6

35.8

u/l

2.31

599

3911

(3036481) Cortisol [Moles/volume] in Serum or Plasma

232

4.42

36.13

2.5

1.6

361.4

379.5

nmol/l

0.33

214

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

176

4.93

35.68

1.5

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

220

909

2.79

35.64

1.8

1.4

1.3

0.8

mg/l

1.09

165

670

(3002032) Base excess in Venous blood by calculation

193

4.72

35.48

3.5

1.7

2.4

mmol/l

0.03

160

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

438

2503

2.30

35.14

3.6

2.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

112

310

3.90

35.10

1.7

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

113

315

3.87

35.06

3.7

1.8

9.0

9.9

ug/l

0.06

234

(4035726)

229

4.37

34.99

1.4

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

112

311

3.88

34.94

1.7

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

250

1115

2.62

34.74

2.3

1.5

—

(3018095) Leukocytes [#/volume] in Urine

345

1788

2.39

34.66

4.5

2.4

70.1

104.9

e6/l

0.42

237

1143

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

163

4.97

34.04

1.5

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

12.93

33.69

2.8

2.1

0.4

u/ml

0.02

(40768797) Stomach Pathology biopsy report

184

711

2.91

33.65

1.2

—

(3030467) Casts [#/volume] in Urine by Automated count

268

1253

2.52

33.63

3.9

2.1

0.3

e6/l

0.09

194

894

(3013512) EKG study

315

1590

2.40

33.38

4.4

2.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

868

6757

3.14

33.34

6.1

3.0

38.8

36.7

mmol/mol

11.63

799

6099

(3019060) Gas panel - Arterial blood

132

5.39

33.15

4.0

3.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

435

2543

2.23

32.33

2.5

1.8

81.0

80.9

nmol/l

0.01

392

2228

(3002582) Erythrocytes [#/volume] in Urine

287

1407

2.43

32.32

3.8

2.2

20.6

51.0

e6/l

1.75

218

1017

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

304

1533

2.38

32.09

3.2

2.0

31.8

30.1

u/l

0.40

285

1456

(3019550) Sodium [Moles/volume] in Serum or Plasma

938

7708

4.65

31.85

17.8

5.6

139.9

140.1

mmol/l

2.86

913

7339

(3023103) Potassium [Moles/volume] in Serum or Plasma

940

7759

4.68

31.18

17.8

5.6

4.0

mmol/l

0.62

914

7360

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

186

754

2.77

30.92

3.2

2.0

0.7

1.0

e6/l

1.31

107

424

(3022313) Gas panel - Capillary blood

104

5.79

30.76

2.6

2.2

—

(3026008) Bacteria identified in Urine by Culture

299

1529

2.33

30.31

3.5

2.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

255

3.92

30.21

2.3

1.9

0.2

g/l

0.18

244

(3042936) Bacteria identified in Isolate by Culture

145

520

3.05

30.13

1.8

1.5

—

(3020891) Body temperature

6.25

29.92

5.8

2.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

264

1290

2.39

29.61

2.7

1.6

7536.5

6101.6

umol/l

0.16

226

1117

(3044889) 12 lead EKG panel

647

4521

2.19

29.50

4.1

2.2

—

(36304419) Bacteria [Presence] in Urine

258

1250

2.40

29.48

4.0

2.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

256

3.86

29.27

2.9

2.3

74.1

73.9

ng/l

0.01

215

(3007164) IgA [Mass/volume] in Serum or Plasma

219

997

2.50

28.60

1.3

2.5

2.3

g/l

0.57

121

571

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

171

690

2.75

28.54

3.2

2.0

1.7

3.1

e6/l

1.41

365

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

884

7119

3.06

28.54

14.1

5.2

80.9

81.1

ml/min/173m2

0.11

738

5301

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

101

5.53

27.37

2.8

1.9

24.9

25.3

mmol/l

0.51

(3007853) Bacteria identified in Skin by Aerobe culture

127

446

3.08

27.27

1.6

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

200

897

2.51

26.82

3.1

1.9

4.2

5.1

e6/l

0.59

172

770

(3018405) Lactate [Moles/volume] in Arterial blood

6.58

26.19

4.9

2.5

1.2

1.1

mmol/l

0.49

(3048689) Calprotectin [Mass/mass] in Stool

163

672

2.67

25.95

2.1

78.1

93.5

ug/g

0.70

127

538

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

129

471

2.96

25.82

2.9

1.8

5.4

7.0

umol/l

0.63

115

403

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

242

1210

2.29

25.27

1.3

1.2

1.6

3.0

u/ml

0.96

323

(3037522) Nuclear Ab [Titer] in Serum

169

725

2.57

24.75

1.3

549.3

578.8

titre

0.07

168

(3026782) Osmolality of Urine

181

804

2.50

24.63

3.2

1.8

582.8

571.6

mosm/kgh2o

0.27

151

661

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

211

1008

2.36

24.42

1.7

1.3

466.5

57952262.0

pmol/l

1.82

173

830

(3052851) Hemolysis interference index of Serum or Plasma

102

5.15

24.00

3.2

2.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

958

8282

5.04

23.84

11.6

5.6

25.0

24.3

u/l

0.71

924

7810

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

9.19

23.58

1.4

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

5.64

22.97

3.6

1.6

24.9

25.1

mmol/l

0.14

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

904

7578

2.99

22.96

5.2

3.2

5.8

5.5

mmol/l

12.67

833

6809

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

936

8031

3.63

22.19

5.4

3.6

2.8

3.1

mmol/l

25.43

864

7274

(3011397) Hemoglobin [Presence] in Urine by Test strip

251

1338

2.14

22.02

4.6

2.7

—

(3021589) Normoblasts [#/volume] in Blood

414

2643

1.94

21.91

9.3

5.2

0.0

e9/l

0.47

321

2147

(3036489) Thrombin time

5.44

21.61

1.7

1.5

24.9

19.7

1.03

(3005719) IgG [Mass/volume] in Serum or Plasma

266

3.31

21.32

2.4

2.5

10.3

10.9

g/l

0.53

248

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

142

4.15

20.51

1.6

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

919

7880

3.04

20.22

4.9

3.4

4.7

5.1

mmol/l

29.47

848

7188

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

176

3.77

20.10

3.0

2.9

4.4

4.7

pmol/l

1.75

161

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

122

495

2.64

19.83

1.8

1.4

1.3

0.96

109

441

(3035350) Ketones [Presence] in Urine by Test strip

445

2991

1.85

19.43

4.2

2.5

0.0

estimate

0.00

466

(3004119) Hemoglobin [Mass/volume] in Venous blood

148

3.97

19.40

2.9

1.7

130.6

138.1

g/l

1.83

148

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

7.17

19.27

1.3

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

7.17

19.27

1.3

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

911

7820

2.82

19.13

4.9

3.4

1.5

1.6

mmol/l

10.56

834

7117

(4010399)

103

391

2.79

19.04

1.5

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

9.28

18.87

1.1

1.0

6.0

2.3

u/ml

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

576

4234

1.82

18.37

2.8

2.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

100

381

2.77

18.35

3.6

1.6

31.2

50.0

u/l

0.90

324

(3021601) Nitrite [Presence] in Urine by Test strip

441

3031

1.79

17.29

5.7

3.5

0.0

estimate

0.00

477

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

152

3.72

17.16

1.6

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

158

770

2.22

17.01

7.3

3.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

197

1049

2.07

16.88

1.3

1.2

11.2

15.6

u/ml

0.34

394

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

873

7453

2.30

16.65

4.4

3.0

1.2

mmol/l

2.70

798

6711

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

4.89

16.64

2.0

1.5

3.5

1.9

ug/l

0.23

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

15.03

16.56

3.3

1.0

22.7

25.1

u/ml

—

(3020630) Protein [Mass/volume] in Serum or Plasma

258

3.02

16.55

2.4

1.5

65.5

67.9

g/l

1.64

228

(3009261) Glucose [Presence] in Urine by Test strip

442

3068

1.76

16.53

4.3

2.5

0.1

0.0

estimate

0.49

484

(3022145) Colonoscopy Study observation

129

587

2.35

16.31

1.5

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

5.01

16.21

3.1

1.6

32.6

mg/l

0.00

(3002256) Pathology report gross observation

145

698

2.23

16.05

1.3

1.1

—

(3019225) pH of Specimen

128

585

2.33

16.01

3.9

2.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

202

1105

2.01

16.00

1.3

1.2

37.9

38.0

iu/ml

0.00

373

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

132

3.80

15.86

1.6

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

106

4.14

15.70

8.7

6.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

262

2.93

15.52

2.7

2.3

—

(4306422)

7.64

15.50

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

7.38

15.06

1.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

224

3.05

14.91

2.2

1.4

—

(3025941) Bacteria identified in Stool by Culture

246

2.95

14.88

1.2

1.1

—

(36660697) Celiac disease serology panel - Serum

103

441

2.46

14.88

1.2

1.1

—

(40761535) Cells panel - Urine sediment

414

2.48

14.56

4.4

2.5

—

(40761511) CBC panel - Blood by Automated count

910

8007

2.47

14.46

14.1

5.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

212

1220

1.91

14.35

3.9

3.2

—

(3051651) Icteric interference index of Serum or Plasma

11.56

14.24

2.4

3.7

—

(4146454)

12.74

14.08

2.2

1.4

—

(3000494) Fungus identified in Specimen by Culture

134

659

2.17

13.99

1.5

1.3

—

(3007461) Platelets [#/volume] in Blood

976

8946

5.53

13.90

23.7

8.3

247.6

253.6

e9/l

2.40

953

8513

(3015171) Extractable nuclear Ab [Units/volume] in Serum

201

3.07

13.87

1.2

0.3

0.2

u/ml

—

(3028026) IgM [Mass/volume] in Serum or Plasma

213

3.00

13.72

1.5

1.6

1.1

1.4

g/l

1.60

197

(3024731) MCV [Entitic volume]

976

8954

5.48

13.71

23.6

8.3

91.2

91.0

0.82

961

8703

(3035941) MCH [Entitic mass]

976

8956

5.46

13.66

23.6

8.3

30.4

0.08

961

8703

(3026361) Erythrocytes [#/volume] in Blood

976

8959

5.44

13.59

23.7

8.3

4.5

4.6

e12/l

6.70

950

8502

(3010813) Leukocytes [#/volume] in Blood

976

8960

5.43

13.56

23.7

8.3

6.4

6.2

e9/l

3.11

950

8501

(3000963) Hemoglobin [Mass/volume] in Blood

976

8963

5.41

13.49

23.8

8.4

135.0

138.3

g/l

12.47

963

8713

(3024928) Oxygen saturation in Venous blood

6.33

13.11

2.2

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

128

3.51

12.75

1.2

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

448

2.31

12.61

1.7

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

181

1031

1.90

12.50

1.8

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

4.96

12.46

1.4

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

400

2.37

12.38

2.0

1.6

65.5

73.0

ml/min/173m2

1.11

115

(3019150) Specific gravity of Urine by Refractometry

214

1290

1.81

12.34

4.9

2.8

1.0

kg/l

0.39

190

(42529406) Shigella sp [Presence] in Stool by Culture

131

3.42

12.32

1.2

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

5.25

12.32

3.3

1.8

—

(3019230) Fractional oxyhemoglobin in Venous blood

6.48

12.20

2.5

1.4

69.8

53.9

1.84

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

128

3.42

12.04

1.1

—

(3037121) Protein [Mass/volume] in Urine

119

3.51

11.93

2.8

1.8

0.1

0.2

g/l

0.65

(3000492) Spirometry study

112

552

2.13

11.58

1.5

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

313

2.48

11.43

2.5

1.8

11.0

16.4

nmol/l

5.11

290

(46235355) HIV 1 and 2 tests - Meaningful Use set

137

731

1.99

11.42

1.9

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

350

2.37

11.00

1.5

1.3

351.5

192.8

u/ml

0.54

319

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

323

2.40

10.68

4.0

1.8

39.8

30.6

u/ml

0.23

316

(3021879) Hepatitis B virus core Ab [Presence] in Serum

313

2.37

10.05

1.5

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

118

3.27

9.99

2.6

2.1

618.7

21.5

u/ml

0.50

106

(3009214) Lutropin [Units/volume] in Serum or Plasma

3.64

9.67

1.4

1.2

13.5

13.1

u/l

0.04

(3000570) Elastase.pancreatic [Mass/mass] in Stool

3.48

9.60

1.6

1.4

293.6

306.8

ug/g

0.13

(3009542) Hematocrit [Volume Fraction] of Blood

805

7023

1.70

9.60

17.7

6.4

40.0

40.3

0.37

582

5270

(3000093) Morphology [Interpretation] in Blood Narrative

7.37

9.57

1.1

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

102

3.37

9.45

1.1

1.0

—

(3017732) Neutrophils [#/volume] in Blood

401

2.17

9.41

2.1

3.7

3.6

e9/l

0.20

309

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

4.03

9.37

1.4

—

(3049717) Cytology report of Urine Cyto stain

162

2.83

9.21

2.0

2.6

—

(4268621)

7.00

9.16

2.3

1.9

—

(40767503) Oxygen content in Capillary blood by calculation

5.93

8.99

1.6

1.4

15.6

17.7

—

(21494434) Karyotype in Bone marrow

7.99

8.74

1.1

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

7.21

8.72

1.6

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

449

2.03

8.29

1.3

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

110

608

1.89

8.21

1.7

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

220

2.46

8.21

1.6

—

(3028707) Methadone [Presence] in Urine by Screen method

14.43

8.15

1.8

1.0

—

(3003338) MCHC [Mass/volume]

764

6667

1.57

8.11

21.2

7.3

332.0

332.8

g/l

1.81

759

6607

(40768443) Skin Pathology biopsy report

255

2.32

7.93

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

3.44

7.82

1.6

1.1

3.4

3.6

mmol/l

0.55

(3004809) Band form neutrophils/100 leukocytes in Blood

4.62

7.76

2.9

1.9

3.9

1.3

0.50

(3048929) Epstein Barr virus Ab [Presence] in Serum

106

3.05

7.61

1.2

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

4.51

7.53

2.3

2.6

—

(40768793) Breast Pathology biopsy report

3.73

7.51

1.3

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

319

2366

1.49

7.47

4.5

2.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

4.85

7.29

2.4

1.9

53.8

55.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

465

1.93

7.19

2.0

1.8

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

121

2.84

7.15

2.8

1.3

2.9

3.0

g/l

0.22

(3021901) Oxygen saturation in Capillary blood

6.30

7.14

1.9

2.7

—

(3028271) Lactate [Moles/volume] in Capillary blood

6.30

7.14

1.2

1.4

2.3

1.5

mmol/l

0.82

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

127

2.78

7.11

2.7

1.3

6.7

7.2

g/l

0.79

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

127

2.78

7.11

2.7

1.3

3.6

3.8

g/l

0.31

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

127

2.78

7.11

2.7

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

156

2.60

7.08

1.3

1.2

3.5

3.4

u/ml

0.02

(1616796) Gas panel - Central venous blood

4.71

7.05

4.2

1.6

—

(4027681)

7.66

7.02

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

163

2.55

6.98

1.3

1.2

69.2

61.6

u/ml

—

(40768795) Lymph node Pathology biopsy report

5.64

6.96

1.5

1.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

129

2.74

6.91

1.2

1.1

1.6

u/ml

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

338

2.06

6.90

1.1

1.2

63.9

99.0

iu/ml

0.66

129

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

3.97

6.78

1.4

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

3.45

6.73

1.3

1.6

1.1

0.8

g/l

0.35

(1002224) Polysomnography panel

210

2.32

6.67

1.1

1.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

155

2.55

6.66

1.3

1.2

2.4

17.1

u/ml

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

230

2.25

6.61

1.5

1.3

35.1

37.4

iu/l

0.16

208

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2.95

6.58

2.3

1.2

37.1

39.3

g/l

0.82

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

12.19

6.54

5.0

3.8

11.4

10.6

mg/l

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

158

2.50

6.41

1.2

1.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

189

2.36

6.38

1.8

1.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

118

2.73

6.33

2.6

1.3

10.7

10.1

g/l

0.34

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

108

2.80

6.21

2.2

1.4

0.5

0.2

g/l

0.37

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

3.34

6.17

1.2

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

4.99

6.13

1.2

1.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

347

1.97

6.09

2.9

2.8

0.4

0.05

(3037756) Immunofixation for Serum or Plasma

3.59

5.93

2.1

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

251

1846

1.46

5.93

1.7

1.5

1.4

1.2

mmol/l

1.97

210

1545

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

6.23

5.87

1.2

1.1

1.2

1.0

u/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

402

1.88

5.85

2.0

1.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

2.99

5.85

1.7

1.3

308.6

1110.5

e6/l

0.43

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

4.00

5.80

1.2

1.1

47.6

48.7

u/l

0.06

(3029937) Albumin [Presence] in Urine by Test strip

219

1575

1.48

5.78

5.1

2.7

0.0

estimate

0.00

476

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

3.20

5.77

1.2

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

126

2.56

5.60

1.2

1.3

—

(44813793)

4.05

5.53

1.2

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2.77

5.53

1.3

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

3.11

5.52

1.1

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

3.28

5.48

1.2

1.1

259.8

262.0

u/ml

0.01

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

4.79

5.41

1.6

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

15.92

5.38

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

15.92

5.38

1.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

3.14

5.37

1.1

1.2

116.5

107.7

u/ml

—

(3021440) Promyelocytes/100 leukocytes in Blood

364

1.88

5.32

3.1

3.0

0.1

0.0

0.30

(3002385) Erythrocyte distribution width [Ratio]

699

6186

1.39

5.25

20.0

6.8

13.7

13.4

2.79

678

5971

(3022806) Fractional oxyhemoglobin in Capillary blood

5.53

5.24

1.1

1.4

89.8

90.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

3.54

5.23

1.5

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

107

2.63

5.21

1.1

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

+∞

5.19

1.6

0.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.84

5.17

1.1

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

3.13

5.10

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

13.26

5.05

1.0

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

9.95

4.99

3.1

2.0

—

(3017181) Myelocytes/100 leukocytes in Blood

372

1.84

4.98

3.1

2.9

0.6

0.5

0.07

(1001926) Buprenorphine [Presence] in Urine by Screen method

2.90

4.94

1.5

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

4.77

4.93

2.3

1.8

—

(3016879) Cocaine [Presence] in Urine

2.70

4.91

1.4

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

3.88

4.90

1.6

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

275

1.95

4.84

1.4

—

(4062490)

3.65

4.84

1.2

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

4.05

4.81

1.3

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

11.37

4.75

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

11.37

4.75

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

4.27

4.75

1.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

4.57

4.70

1.2

1.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

3.57

4.68

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

3.57

4.68

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

102

2.56

4.62

1.2

—

970.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

103

664

1.59

4.47

1.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

143

992

1.50

4.47

5.3

3.7

33.0

32.0

0.54

107

559

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

3.40

4.39

3.1

3.9

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

3.99

4.36

2.0

1.3

3.7

3.2

u/l

—

(3025159) Blasts/100 leukocytes in Blood

352

1.79

4.32

3.1

3.0

0.0

0.1

0.49

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

412

1.73

4.31

2.9

1.7

—

(3027944) Amphetamines [Presence] in Urine

112

2.42

4.30

1.4

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

3.70

4.29

1.5

1.4

—

(3044927) Protein electrophoresis panel - Urine

3.70

4.29

1.3

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

8.84

4.25

1.5

1.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2.59

4.22

1.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

3.03

4.16

1.1

—

(3011648) Oxygen content in Venous blood

6.89

4.13

2.0

1.4

11.9

9.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

322

1.79

4.05

1.1

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

2.98

4.04

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

2.98

4.04

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

2.98

4.04

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

2.98

4.04

1.1

—

(4094501)

135

2.23

4.00

1.1

—

(3027008) Opiates [Presence] in Urine

110

2.37

3.98

1.4

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

3.50

3.98

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

3.50

3.98

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

3.50

3.98

1.2

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

2.93

3.93

1.1

—

(3028300) Cannabinoids [Presence] in Urine

111

2.35

3.91

1.4

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

111

2.35

3.91

1.4

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

2.67

3.91

1.4

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

3.41

3.83

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

3.41

3.83

1.2

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

3.41

3.83

1.5

1.1

4.2

3.9

ug/l

0.02

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

3.41

3.83

1.2

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

2.88

3.82

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

4.15

3.82

1.5

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

4.15

3.82

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

107

2.34

3.75

1.3

1.9

2.3

2.4

iu/l

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

11.91

3.74

1.2

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

11.91

3.74

1.2

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

3.78

3.74

1.2

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

2.64

3.65

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

154

2.09

3.64

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

6.63

3.64

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

6.63

3.64

1.1

1.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

136

2.14

3.53

1.7

1.6

13759.5

9543.2

e6/l

0.28

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

7.73

3.53

1.3

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

7.73

3.53

1.3

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

7.73

3.53

1.3

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

3.32

3.41

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

4.97

3.34

2.6

1.1

31.2

34.7

—

(3042631) Mycobacterium sp identified in Specimen

3.08

3.30

1.6

3.5

—

(40768800) Prostate Pathology biopsy report

2.82

3.29

1.1

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.42

3.27

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

8.51

3.24

1.2

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

8.51

3.24

1.2

1.1

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

8.51

3.24

1.0

3.1

72.0

74.7

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

8.51

3.24

1.0

3.1

295.7

971.9

mu/l

—

(40768441) Liver Pathology biopsy report

4.71

3.20

1.8

1.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

129

2.10

3.16

2.0

2.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

3.55

3.14

1.7

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

4.48

3.08

1.2

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

4.48

3.08

1.4

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

2.40

3.07

1.0

1.2

—

(3023410) Appearance of Cerebral spinal fluid

3.06

3.03

1.4

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

2.79

3.02

1.0

1.1

—

(3012441) Differential panel - Pleural fluid

4.97

3.02

1.1

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

242

1952

1.30

3.00

5.8

3.6

1.8

2.3

ug/l

2.66

216

1789

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2.67

2.99

1.3

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

2.67

2.99

1.1

1.0

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

3.43

2.99

1.4

12.3

10.4

umol/l

—

(3006653) Thiamine [Moles/volume] in Blood

4.26

2.96

1.0

146.4

125.1

nmol/l

—

(3021788) Differential panel - Synovial fluid

106

2.17

2.96

1.5

—

(3044941) Cell count panel - Synovial fluid

2.30

2.94

1.6

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.99

2.91

1.1

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.99

2.91

1.1

1.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

2.99

2.91

1.4

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

2.23

2.89

1.1

0.9

3.1

u/ml

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

2.53

2.89

1.6

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

3.13

2.87

4.1

1.9

—

(3045142) Bone marrow Pathology biopsy report

4.07

2.85

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

5.35

2.84

4.3

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

2.58

2.81

1.6

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

3.04

2.75

1.3

1.0

—

nmol/l

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

3.89

2.74

2.1

1.5

15.0

16.3

nmol/l

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2.22

2.73

1.9

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

2.53

2.72

1.1

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

4.97

2.70

1.4

2.7

—

(3047189) Immunofixation for 24 hour Urine

5.95

2.67

2.0

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

2.19

2.67

1.1

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

2.19

2.67

1.1

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

4.18

2.65

1.7

1.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

334

1.60

2.61

3.1

1.8

1.2

mmol/l

0.30

259

(3003694) ABO and Rh group [Type] in Blood

215

1744

1.28

2.53

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

7.08

2.53

1.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

5.41

2.52

1.2

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

5.41

2.52

1.2

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

5.41

2.52

1.2

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

5.41

2.52

1.2

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

170

1.83

2.52

1.4

1.3

—

(3025130) Human papilloma virus identified in Specimen

2.12

2.48

1.6

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

4.34

2.45

1.4

1.1

—

(40768806) Pleura Pathology biopsy report

4.34

2.45

1.1

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

2.37

2.40

1.5

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

4.96

2.38

1.0

1.1

114.5

115.8

—

(3017569) Oxygen content in Arterial blood

6.20

2.35

1.8

2.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

6.20

2.35

2.0

1.4

0.3

0.6

ug/l

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

4.09

2.33

1.4

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

4.09

2.33

1.4

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

4.09

2.33

1.4

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

2.40

2.31

2.4

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

146

1.85

2.31

1.5

1.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

3.19

2.28

1.2

1.8

3.1

2.3

mg/l

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

191

1.73

2.27

1.6

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

4.58

2.25

1.5

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

4.58

2.25

1.0

1.5

8.8

9.2

ug/l

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

2.67

2.23

1.9

2.4

5.6

4.3

umol/l

0.24

(3045788) Cell count panel - Pleural fluid

3.86

2.23

1.1

1.3

—

(3008898) HLA-B27 [Presence]

231

1.65

2.20

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

127

1.89

2.20

2.9

1.9

493.9

3736.1

u/l

1.79

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

247

1.62

2.18

1.9

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

3.31

2.15

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

3.31

2.15

1.4

1.7

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

4.25

2.13

2.8

1.3

110.7

56.4

nmol/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

3.66

2.12

2.0

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

2.02

2.10

1.1

0.3

0.5

u/ml

—

(3035320) C reactive protein [Mass/volume] in Body fluid

2.88

2.04

2.1

1.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.47

2.03

1.0

1.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

194

1599

1.25

1.99

5.0

3.5

23.4

22.9

0.18

791

(3011288) Drugs identified in Urine by Screen method

2.39

1.98

2.1

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

3.31

1.94

1.0

1.3

9.1

11.4

u/l

—

(3014271) Vancomycin [Susceptibility]

4.51

1.92

2.0

1.8

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

3.72

1.91

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

112

1.87

1.90

1.1

0.6

1.1

u/ml

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

2.18

1.89

3.1

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

2.10

1.87

1.2

1.7

61.5

50.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

2.84

1.83

1.3

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1.97

1.80

1.1

—

43.6

—

(3016018) Differential panel - Cerebral spinal fluid

2.48

1.79

1.4

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

3.02

1.77

1.9

1.7

676.7

880.9

u/ml

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

2.25

1.76

1.0

1.1

—

(44790049)

2.89

1.70

1.6

1.3

—

(44790048)

2.89

1.70

1.6

1.3

—

(44806118)

2.89

1.70

1.6

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.89

1.70

1.0

1.1

—

(44790047)

2.89

1.70

1.6

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.81

1.69

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

297

1.48

1.68

1.5

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

163

1.65

1.1

1.3

174.5

227.6

miu/ml

—

(3041096) Erythrocytes [Presence] in Urine by Automated

196

1651

1.22

1.64

3.2

2.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

587

1.34

1.63

1.4

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.78

1.62

1.0

1.1

1879.1

1424.5

miu/ml

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

2.09

1.61

1.2

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

3.54

1.60

1.0

2.1

129.7

41.5

ug/l

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.97

1.56

1.2

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.67

1.56

1.4

1.3

—

(3045414) Leukocytes [Presence] in Urine

303

1.45

1.55

2.1

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

144

1185

1.23

1.51

3.1

2.7

0.8

ug/l

0.10

774

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.30

1.50

1.0

1.9

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

3.30

1.50

1.4

3.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.30

1.50

1.2

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

1.96

1.49

2.8

1.9

6.2

6.3

mmol/l

0.24

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

2.57

1.49

1.0

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

2.83

1.48

1.3

1.1

172.5

214.1

u/l

—

(3037556) Urate [Mass/volume] in Serum or Plasma

2.83

1.48

1.3

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

349

0.61

1.47

1.3

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

2.14

1.46

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

1.93

1.44

2.8

1.9

1.3

mmol/l

0.02

(3029075) Extractable nuclear Ab panel - Serum

3.10

1.42

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

2.70

1.41

1.3

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.70

1.41

1.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1.87

1.40

3.4

3.3

57.3

56.7

0.06

(3030905) Polymorphonuclear cells [#/volume] in Blood

1.87

1.40

3.4

3.3

4.4

3.8

e9/l

0.51

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.91

1.34

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.75

1.24

1.6

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

169

1.53

1.23

1.7

1.6

0.2

0.1

iu/ml

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

2.20

1.23

2.1

2.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

2.20

1.23

1.8

1.3

—

(3000330) Specific gravity of Urine by Test strip

299

1.37

1.11

3.3

2.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

385

1.33

1.11

1.5

—

(4281824)

1.88

1.08

1.1

—

(3023419) Bacteria identified in Sputum by Culture

1.91

1.03

1.6

2.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

244

1.39

1.02

1.7

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

2.04

1.01

1.0

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.98

0.99

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.93

0.95

1.3

—

(3035285) Chloride [Moles/volume] in Venous blood

1.87

0.92

1.3

106.1

106.6

mmol/l

—

(3041354) Potassium [Moles/volume] in Venous blood

1.87

0.92

1.3

3.8

4.1

mmol/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

159

1387

1.16

0.92

1.5

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

149

1.47

0.91

1.8

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

2.05

0.88

1.2

185.2

199.1

u/l

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.57

0.84

1.4

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.76

0.83

1.6

1.3

—

(40761536) Microorganisms panel - Urine sediment

414

1.25

0.81

3.8

2.5

—

(4133840)

0.00

0.79

0.0

1.3

—

(3022621) pH of Urine by Test strip

425

1.24

0.78

2.7

2.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.80

0.78

1.2

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.06

0.74

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

825

0.84

0.72

1.6

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.50

0.72

1.2

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.98

0.72

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

1.90

0.70

1.2

1.8

0.8

1.2

u/field

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.54

0.69

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

325

1.26

0.68

1.5

1.3

2.2

2.8

mg/l

0.44

205

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.83

0.67

4.4

2.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.65

0.60

1.2

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

129

1.39

0.60

5.1

2.4

—

(4024509)

1.57

0.59

1.3

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

0.58

0.0

1.7

—

8.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

552

0.83

0.57

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1.65

0.56

1.2

1.3

—

(4034850)

215

1.25

0.47

7.8

4.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

162

0.73

0.45

1.4

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1.42

0.43

1.0

1.1

1.7

2.9

u/ml

—

(1761868) Lipid panel - Serum or Plasma

277

2873

0.93

0.43

2.9

2.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

1.60

0.42

1.0

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

181

0.76

0.41

1.6

1.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1.35

0.37

1.8

1.9

13.3

13.1

0.43

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

118

1.26

0.31

1.3

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.26

0.29

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.27

0.22

1.8

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.21

0.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(21494755) Public health laboratory ask at order entry panel

800

1.07

0.21

1.2

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.20

0.0

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.20

0.0

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.13

0.17

1.3

1.1

—

(3005033) Fetal Nuchal fold Thickness US

1.22

0.17

1.5

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

129

0.84

0.16

1.5

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.21

0.15

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.21

0.15

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

102

1.07

0.01

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

102

1.07

0.01

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

103

1.06

0.00

1.5

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

103

1.06

0.00

1.5

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

107

1.02

0.00

1.5

—

(3045424) Erythrocytes [Presence] in Urine

122

0.97

0.00

1.3

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

258

1.00

0.00

1.7

1.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.00

0.0

1.6

—

(3007916) DNA double strand Ab [Titer] in Serum

0.00

0.0

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

1.0

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.0

1.0

—

(3003129) Base excess in Capillary blood by calculation

0.00

0.0

3.2

—

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.0

4.6

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

1.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.0

—

7.4

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

0.0

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.0

1.0

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

10.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

358.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.0

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint ANOSMIA and mortality.

Females

Parameter	HR [95% CI]	p-value
ANOSMIA	0.808 [0.71, 0.92]	0.002
Birth year	0.996 [0.99, 1.0]	0.364

During the follow-up period (1.1.1998 — 31.12.2019), 303 out of 3408 females with ANOSMIA died.

Males

Parameter	HR [95% CI]	p-value
ANOSMIA	0.872 [0.75, 1.01]	0.076
Birth year	0.986 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 253 out of 1920 males with ANOSMIA died.

Mortality risk

Mortality risk for people of age

years, who have ANOSMIA.

N-year risk	Females	Males
1	0.081%	0.157%
5	0.549%	0.977%
10	1.229%	2.494%
15	2.272%	4.668%
20	4.087%	8.128%

Relationships between endpoints

↥

Index endpoint: ANOSMIA – Anosmia

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Anosmia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints